Currently, there are 1.92B common shares owned by the public and among those 1.91B shares have been available to trade.
The company’s stock has a 5-day price change of -0.60% and -9.22% over the past three months. KVUE shares are trading -14.96% year to date (YTD), with the 12-month market performance down to -28.75% lower. It has a 12-month low price of $17.75 and touched a high of $26.25 over the same period. KVUE has an average intraday trading volume of 21.66 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.69%, -4.32%, and -8.00% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Kenvue Inc (NYSE: KVUE) shares accounts for 89.89% of the company’s 1.92B shares outstanding.
It has a market capitalization of $35.06B and a beta (3y monthly) value of 1.35. The stock’s trailing 12-month PE ratio is 23.53, while the earnings-per-share (ttm) stands at $0.78. The company has a PEG of 17.56 and a Quick Ratio of 0.68 with the debt-to-equity ratio at 0.82. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.91% over the week and 2.23% over the month.
Earnings per share for the fiscal year are expected to decrease by -11.24%, and 6.91% over the next financial year. EPS should shrink at an annualized rate of 1.34% over the next five years, compared to 3.41% over the past 5-year period.
Looking at the support for the KVUE, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on May 28, 2024, with the firm’s price target at $21. Bernstein coverage for the Kenvue Inc (KVUE) stock in a research note released on April 11, 2024 offered a Underperform rating with a price target of $18. William Blair was of a view on April 03, 2024 that the stock is Mkt Perform, while Goldman gave the stock Neutral rating on March 01, 2024, issuing a price target of $20. Piper Sandler on their part issued Neutral rating on November 17, 2023.
